Pharmaceutical development and preclinical evaluation of a GMP-grade anti-inflammatory nanotherapy

The present study describes the development of a good manufacturing practice (GMP)-grade liposomal nanotherapy containing prednisolone phosphate for the treatment of inflammatory diseases. After formulation design, GMP production was commenced which yielded consistent, stable liposomes sized 100 nm...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Nanomedicine
Main Authors: Lobatto, Mark E., Calcagno, Claudia, Otten, Maarten J., Millon, Antoine, Ramachandran, Sarayu, Paridaans, Maarten P.M., van der Valk, Fleur M., Storm, Gert J., Stroes, Erik S.G., Fayad, Zahi A., Mulder, Willem J.M., Metselaar, Josbert M.
Formato: Artigo
Idioma:Inglês
Publicado: 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4495976/
https://ncbi.nlm.nih.gov/pubmed/25791805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2015.02.020
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares